Active Filters

Joseph Unger, PhD, MS
Jul 29, 2021
Study of federally funded research finds overall enrollment to treatment trials changed little, while enrollment to cancer control and prevention studies fell substantially.
JCO Oncology Practice
Jul 23, 2021
Pretreatment fatigue can mean worse survival outcomes for patients with cancer
Kenneth Grossmann, MD, PhD, S1404 lead investigator
Jun 3, 2021
Immune therapy after surgery lowers relapse risk in patients with high-risk melanoma
DEI Cover Banner
May 10, 2021
New Initiative Aims to Improve Representation in Cancer Clinical Trials